TFO
BMY.RT

Tarbox Family Office’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Tarbox Family Office’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-36
Closed – – 1186
2020
Q4 		$0 Hold
36
– – ﹤0.01% 1215
2020
Q3 		$0 Sell
36
-1,000
-97% -$2.86K ﹤0.01% 1225
2020
Q2 		$4K Sell
1,036
-2,308
-69% -$8.33K ﹤0.01% 578
2020
Q1 		$13K Buy
3,344
+8
+0.2% +$26 ﹤0.01% 299
2019
Q4 		$10K Buy
+3,336
New +$8.68K ﹤0.01% 389

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Tarbox Family Office's BMY.RT Position: Q1 2021 in Review

Tarbox Family Office sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 36 shares.

Tarbox Family Office first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $13K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Tarbox Family Office reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Tarbox Family Office sold 36 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Tarbox Family Office first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Tarbox Family Office's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $13K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Tarbox Family Office's 13F filing for Q1 2021, filed 27 Apr 2021.